Life Sciences/Biotech

NanoBio Gets $6 Million Grant From Gates Foundation For RSA Vaccine

ANN ARBOR - NanoBio Corporation announced Tuesday that it has received a $6 million grant from the Bill & Melinda Gates Foundation to support the development of a safe and effective intranasal vaccine for Respiratory Syncytial Virus, a highly contagious viral disease and is one of the most common causes of bronchiolitis and pneumonia. RSA

By |2010-11-30T00:00:00-05:00November 30th, 2010|Archive, Life Sciences/Biotech|

Wayne State Professor Gets $1 Million Grant To Study Cardiovascular Disease

DETROIT - Wayne State University physiology assistant professor Patrick J. Mueller has been awarded a $1 million grant from the National Institutes of Health to study how alterations in the brain caused by inactivity may contribute to an individual's risk of cardiovascular disease. Physical inactivity is considered a major risk factor of cardiovascular disease, the

By |2010-11-24T00:00:00-05:00November 24th, 2010|Archive, Life Sciences/Biotech|

MarketLab To Acquire Newmatic Medical

CALEDONIA, Mich. - MarketLab Inc., which is a catalog supplier of specialty products and services for healthcare professionals, announced Monday that it has signed a definitive agreement to acquire substantially all of the assets of Petulama, Calif.-based Newmatic Medical. Terms of the transaction were not disclosed. Newmatic Medical is a direct marketer of MRI products

By |2010-11-22T00:00:00-05:00November 22nd, 2010|Archive, Life Sciences/Biotech|

MI Molecular Institute Adds 1 Polymer Experts, Promotes 2 From Inside

MIDLAND - Michigan Molecular Institute recently added two new polymer experts to its ranks, while two other MMI research scientists earned promotions. Joining the MMI research staff were Patrick Smith and Edmund Stark. Promoted were Claire Hartmann-Thompson and Steven Kaganove, both to the level of Research Scientists. All hold PhDs. Smith comes to MMI following

By |2010-11-14T00:00:00-05:00November 14th, 2010|Archive, Life Sciences/Biotech|

MyMACWellness.Com To Address Low Fitness Levels Among Tech Workers

LANSING - A recent study shows that workers in the high tech industry are acutely susceptible to heart disease and other problems due to the nature of their sedentary desk life. But a new web site aims to reverse this trend. MyMACWellness.Com provides local listings of free and low-cost activities. With an easy, point-and-click design,

By |2010-11-02T00:00:00-04:00November 2nd, 2010|Archive, Life Sciences/Biotech|

Walsh Webinar Nov. 18 Outlines Health Services Administration Degrees

TROY - Join a free Walsh College webinar on Thursday, Nov. 18, to get an overview of the Walsh Health Services Administration specialization, designed for professionals who work in the health services field or aspire to do so. Courses include health economics; health administration finance; health care policy, law and ethical issues; and quality assurance

By |2010-11-02T00:00:00-04:00November 2nd, 2010|Archive, Life Sciences/Biotech|

Karmanos Cancer Institute Breast Cancer Researchers Win $3 Million NIH Grant

DETROIT - Scientists at the Barbara Ann Karmanos Cancer Institute in Detroit have received a nearly $3 million, five-year research project grant from the National Institutes of Health to study a potentially ground-breaking immunotherapy treatment for women with one of the deadliest forms of breast cancer ? triple-negative breast cancer. The research is exclusive to

By |2010-10-19T00:00:00-04:00October 19th, 2010|Archive, Life Sciences/Biotech|

California’s InTouch Health To Locate R&D Lab In Ann Arbor

ANN ARBOR ? Ann Arbor SPARK said it recently attracted InTouch Health to locate a research and development operation at Valley Ranch Business Park in Pittsfield Township. Ann Arbor SPARK provided site selection and talent recruitment support to InTouch Health. "InTouch Health chose Ann Arbor because of its rich software development talent pool, including experienced

By |2010-10-17T00:00:00-04:00October 17th, 2010|Archive, Life Sciences/Biotech|

Asterand Wins 5-Year, $24.3 Million Contract From National Cancer Institute

DETROIT - Asterand plc, a leading provider of human tissue and human tissue-based services to pharmaceutical and biotechnology companies engaged in drug discovery research, has been awarded a five-year, $24.3 million contract with the National Cancer Institute to supply clinically annotated human biospecimens for The Cancer Genome Atlas project, which attempts to understand the molecular

By |2010-10-05T00:00:00-04:00October 5th, 2010|Archive, Life Sciences/Biotech|